x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
¨
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
Delaware
|
36-3680347
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
incorporation
or organization)
|
Identification
No.)
|
Page
|
||
PART
I
|
Financial
Information
|
2
|
ITEM
1.
|
Financial
Statements
|
2
|
ITEM
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
26
|
ITEM
3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
31
|
ITEM
4.
|
Controls
and Procedures
|
31
|
PART
II
|
Other
Information
|
32
|
ITEM
1.
|
Legal
Proceedings
|
32
|
ITEM 1A.
|
Risk
Factors
|
33
|
ITEM
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
33
|
ITEM
3.
|
Defaults
Upon Senior Securities
|
33
|
ITEM
4.
|
(Removed
and Reserved)
|
33
|
ITEM
5.
|
Other
Information
|
33
|
ITEM
6.
|
Exhibits
|
34
|
Signatures
|
41
|
June
30,
|
December
31,
|
|||||||
2010
|
2009
|
|||||||
|
(Unaudited)
|
|||||||
ASSETS | ||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 673 | $ | 198 | ||||
Trade
accounts receivable
|
236 | 374 | ||||||
Inventories,
net of allowance of $113 and $136
|
100 | 124 | ||||||
Prepaid
expenses and other current assets
|
122 | 294 | ||||||
Total
current assets
|
1,131 | 990 | ||||||
Property
and equipment, net
|
96 | 129 | ||||||
Goodwill
|
3,418 | 3,418 | ||||||
Proprietary
software, net
|
1,745 | 2,076 | ||||||
Patents
and other intangible assets, net
|
1,870 | 1,996 | ||||||
Cash
surrender value of life insurance policies
|
612 | 659 | ||||||
Other
long-term assets
|
186 | 156 | ||||||
Total
assets
|
$ | 9,058 | $ | 9,424 | ||||
LIABILITIES
AND SHAREHOLDERS’ DEFICIT
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$ | 357 | $ | 558 | ||||
Taxes
payable
|
5 | 4 | ||||||
Accrued
expenses
|
8,132 | 7,292 | ||||||
Deferred
revenues and customer prepayments
|
459 | 791 | ||||||
Note
payable
|
15 | 69 | ||||||
Note
payable - YA Global
|
- | 500 | ||||||
Accrued
purchase price guarantee
|
4,535 | 4,535 | ||||||
Deferred
tax liability
|
706 | 706 | ||||||
Derivative
financial instruments - warrants
|
2,399 | 9,912 | ||||||
Derivative
financial instruments - Series C and D preferred stock and debentures
payable
|
7,422 | 50,985 | ||||||
Debentures
payable - carried at amortized cost
|
14,411 | 12,523 | ||||||
Debentures
payable - carried at fair value
|
19,864 | 37,678 | ||||||
Total
current liabilities
|
58,305 | 125,553 | ||||||
Commitments
and contingencies (Note 7)
|
||||||||
Series
C convertible preferred stock, $0.01 par value, 27,000
|
||||||||
shares
authorized, 8,642 and 8,642 shares issued and
outstanding,
|
||||||||
liquidation
value of $8,642 and $8,642
|
8,642 | 8,642 | ||||||
Series
D convertible preferred stock, $0.01 par value, 25,000
|
||||||||
shares
authorized, 25,000 and 0 shares issued and outstanding,
|
||||||||
liquidation
value of $2,500 and $0
|
2,500 | - | ||||||
Shareholders’
deficit:
|
||||||||
Common
stock, $0.001 par value, 5,000,000,000 shares authorized, 22,707,093
and
|
||||||||
22,707,093
shares issued and 22,675,678 and 22,675,678 shares
|
||||||||
outstanding,
respectively
|
23 | 23 | ||||||
Additional
paid-in capital
|
153,157 | 153,059 | ||||||
Accumulated
deficit
|
(212,651 | ) | (276,985 | ) | ||||
Accumulated
other comprehensive loss
|
(139 | ) | (89 | ) | ||||
Treasury
stock, at cost, 2,012 shares of common stock
|
(779 | ) | (779 | ) | ||||
Total
shareholders’ deficit
|
(60,389 | ) | (124,771 | ) | ||||
Total
liabilities and shareholders’ deficit
|
$ | 9,058 | $ | 9,424 |
Three Months Ended
|
||||||||
June 30,
|
June 30,
|
|||||||
2010
|
2009
|
|||||||
Revenues
|
$ | 221 | $ | 136 | ||||
Cost
of revenues
|
255 | 281 | ||||||
Gross
profit (deficit)
|
(34 | ) | (145 | ) | ||||
Sales
and marketing expenses
|
262 | 178 | ||||||
General
and administrative expenses
|
1,041 | 863 | ||||||
Research
and development costs
|
418 | 350 | ||||||
Operating
loss
|
(1,755 | ) | (1,536 | ) | ||||
Gain
(loss) on extinguishment of debt
|
(363 | ) | - | |||||
Gain
(loss) from change in fair value of hybrid financial
instruments
|
1,180 | 23,343 | ||||||
Gain
(loss) from change in fair value of derivative liability -
warrants
|
4,305 | 20,879 | ||||||
Gain
(loss) from change in fair value of derivative liability -
|
||||||||
Series
C and D preferred stock and debentures
|
6,645 | 37,978 | ||||||
Interest
expense related to convertible debt
|
(510 | ) | (2,600 | ) | ||||
Net
income (loss)
|
9,502 | 78,064 | ||||||
Dividends
on convertible preferred stock
|
- | (368 | ) | |||||
Net
income (loss) attributable to common shareholders
|
9,502 | 77,696 | ||||||
Comprehensive
income (loss):
|
||||||||
Net
income (loss)
|
9,502 | 78,064 | ||||||
Other
comprehensive income (loss):
|
||||||||
Foreign
currency translation adjustment
|
(26 | ) | (22 | ) | ||||
Comprehensive
income (loss)
|
$ | 9,476 | $ | 78,042 | ||||
Net
income (loss) per share, basic and diluted:
|
||||||||
Basic
|
$ | 0.42 | $ | 4.89 | ||||
Fully
diluted
|
$ | (0.01 | ) | $ | 0.25 | |||
Weighted
average number of common shares:
|
||||||||
Basic
|
22,675,678 | 15,882,816 | ||||||
Fully
diluted
|
302,104,430 | 67,928,736 |
Six Months Ended
|
||||||||
June 30,
|
June 30,
|
|||||||
2010
|
2009
|
|||||||
Revenues
|
$ | 576 | $ | 626 | ||||
Cost
of revenues
|
594 | 808 | ||||||
Gross
profit (deficit)
|
(18 | ) | (182 | ) | ||||
Sales
and marketing expenses
|
581 | 464 | ||||||
General
and administrative expenses
|
2,136 | 1,787 | ||||||
Research
and development costs
|
701 | 673 | ||||||
Operating
loss
|
(3,436 | ) | (3,106 | ) | ||||
Gain
(loss) on extinguishment of debt
|
(6,006 | ) | - | |||||
Gain
(loss) from change in fair value of hybrid financial
instruments
|
19,552 | 312 | ||||||
Gain
(loss) from change in fair value of derivative liability -
warrants
|
10,856 | (12,402 | ) | |||||
Gain
(loss) from change in fair value of derivative liability -
|
||||||||
Series
C and D preferred stock and debentures
|
46,824 | (9,676 | ) | |||||
Interest
expense related to convertible debt
|
(956 | ) | (3,663 | ) | ||||
Net
income (loss)
|
66,834 | (28,535 | ) | |||||
Dividends
on convertible preferred stock
|
(2,500 | ) | (743 | ) | ||||
Net
income (loss) attributable to common shareholders
|
64,334 | (29,278 | ) | |||||
Comprehensive
income (loss):
|
||||||||
Net
income (loss)
|
66,834 | (28,535 | ) | |||||
Other
comprehensive income (loss):
|
||||||||
Foreign
currency translation adjustment
|
(50 | ) | (79 | ) | ||||
Comprehensive
income (loss)
|
$ | 66,784 | $ | (28,614 | ) | |||
Net
income (loss) per share, basic and diluted:
|
||||||||
Basic
|
$ | 2.84 | $ | (1.98 | ) | |||
Fully
diluted
|
$ | (0.02 | ) | $ | (1.98 | ) | ||
Weighted
average number of common shares:
|
||||||||
Basic
|
22,675,678 | 14,785,746 | ||||||
Fully
diluted
|
299,092,068 | 14,785,746 |
Common
Stock
|
Additional
Paid-in
|
Accumulated Other
Comprehensive
|
Accumulated |
Treasury
Stock
|
Total
Shareholders'
Equity
|
|||||||||||||||||||||||||||
Shares
|
Amount
|
Capital
|
Income
(Loss)
|
Deficit
|
Shares
|
Amount
|
(Deficit)
|
|||||||||||||||||||||||||
Balance,
December 31, 2009, as previously reported
|
22,675,678 | $ | 22,676 | $ | 130,406 | $ | (89 | ) | $ | (276,985 | ) | 2,012 | $ | (779 | ) | $ | (124,771 | ) | ||||||||||||||
Effect
of 1 for 100 share reverse stock split and change in par
value
|
- | (22,653 | ) | 22,653 | - | - | - | - | - | |||||||||||||||||||||||
Balance,
December 31, 2009, after retroactive
adjustment
|
22,675,678 | 23 | 153,059 | (89 | ) | (276,985 | ) | 2,012 | (779 | ) | (124,771 | ) | ||||||||||||||||||||
Deemed dividend on
Series D Preferred Stock issued
to YA Global
|
(2,500 | ) | (2,500 | ) | ||||||||||||||||||||||||||||
Stock-based
compensation expense
|
- | - | 98 | - | - | - | - | 98 | ||||||||||||||||||||||||
Comprehensive
income - foreign currency translation
adjustment
|
- | - | - | (50 | ) | - | - | - | (50 | ) | ||||||||||||||||||||||
Net
income
|
- | - | - | - | 66,834 | - | - | 66,834 | ||||||||||||||||||||||||
Balance,
June 30, 2010
|
22,675,678 | $ | 23 | $ | 153,157 | $ | (139 | ) | $ | (212,651 | ) | 2,012 | $ | (779 | ) | $ | (60,389 | ) |
Six Months Ended
|
||||||||
June 30,
|
||||||||
2010
|
2009
|
|||||||
Cash
Flows from Operating Activities:
|
||||||||
Net
income (loss)
|
$ | 66,834 | $ | (28,535 | ) | |||
Adjustments
to reconcile net income (loss) to net cash used in operating
activities:
|
||||||||
Depreciation
and amortization
|
497 | 512 | ||||||
(Gain)
loss on extinguishment of debt
|
6,006 | - | ||||||
(Gain)
loss from change in fair value of hybrid financial
instruments
|
(19,552 | ) | (312 | ) | ||||
(Gain)
loss from change in fair value of derivative liability -
warrants
|
(10,856 | ) | 12,402 | |||||
(Gain)
loss from change in fair value of derivative liability -
|
||||||||
Series
C and D preferred stock and debentures
|
(46,824 | ) | 9,676 | |||||
Interest
expense related to convertible debt
|
956 | 3,663 | ||||||
Stock-based
compensation expense
|
98 | 177 | ||||||
Decrease
(increase) in value of life insurance policies
|
47 | (58 | ) | |||||
Changes
in operating assets and liabilities
|
||||||||
Trade
and other accounts receivable
|
138 | 46 | ||||||
Inventories
|
24 | (50 | ) | |||||
Prepaid
expenses and other assets
|
142 | 113 | ||||||
Accounts
payable and accrued liabilities
|
(537 | ) | (198 | ) | ||||
Deferred
revenue and other current liabilities
|
(332 | ) | (124 | ) | ||||
Net
cash used in operating activities
|
(3,359 | ) | (2,688 | ) | ||||
Cash
Flows from Investing Activities:
|
||||||||
Acquisition
of property and equipment
|
(7 | ) | (24 | ) | ||||
Net
cash provided by (used in) investing activities
|
(7 | ) | (24 | ) | ||||
Cash
Flows from Financing Activities:
|
||||||||
Proceeds
from issuance of Series D convertible preferred stock
|
2,500 | - | ||||||
Costs
attributed to issuance of Series D convertible preferred
stock
|
(100 | ) | - | |||||
Repayment
of note payable - YA Global
|
(500 | ) | - | |||||
Borrowings
under convertible debt instruments, net
|
1,885 | 1,660 | ||||||
Net
proceeds from exercise of stock options
|
- | 116 | ||||||
Net
cash provided by financing activities
|
3,785 | 1,776 | ||||||
Effect
of exchange rate changes on cash
|
56 | (20 | ) | |||||
Net
increase (decrease) in cash and cash equivalents
|
475 | (956 | ) | |||||
Cash
and cash equivalents, beginning of period
|
198 | 1,259 | ||||||
Cash
and cash equivalents, end of period
|
$ | 673 | $ | 303 | ||||
Supplemental
cash flow information:
|
||||||||
Interest
paid during the period
|
$ | 1 | $ | 3 | ||||
Accretion
of dividends on Series C Convertible Preferred Stock
|
$ | - | $ | 743 | ||||
Series
C Convertible Preferred Stock converted to common stock
|
$ | - | $ | 720 | ||||
Deemed
dividend on Series D Convertible Preferred Stock issued
|
$ | 2,500 | $ | 1,337 | ||||
Fair
value of common shares issued to satisfy purchase price guarantee
obligations
|
$ | - | $ | 445 |
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
(in thousands except share and per share data)
|
||||||||||||||||
Numerator:
|
||||||||||||||||
Net
income (loss)
|
$ | 9,502 | $ | 78,064 | $ | 66,834 | (28,535 | ) | ||||||||
Adjustments
to reconcile net income to income (loss)
|
||||||||||||||||
applicable
to common stockholders:
|
||||||||||||||||
Accretion
of preferred stock dividends
|
- | (368 | ) | (2,500 | ) | (743 | ) | |||||||||
Numerator
for basic earnings per share - income available to common
stockholders
|
$ | 9,502 | $ | 77,696 | $ | 64,334 | $ | (29,278 | ) | |||||||
Effect
of dilutive securities:
|
||||||||||||||||
Adjustment
for change in fair value of derivative liability-Series C and
D preferred stock and debentures
|
(6,645 | ) | (37,978 | ) | (46,824 | ) | - | |||||||||
Adjustment
for change in fair value of derivative liability- warrants
|
(4,305 | ) | - | (10,856 | ) | - | ||||||||||
Adjustment
for loss on extinguishment of debt
|
- | 5,643 | - | |||||||||||||
Adjustment
for change in fair value of hybrid financial instruments
|
(1,180 | ) | (23,343 | ) | (19,552 | ) | - | |||||||||
Adjustment
for dividends on convertible preferred stock
|
- | 368 | - | - | ||||||||||||
Adjustment
for interest expense related to convertible debt
|
478 | - | 927 | - | ||||||||||||
(11,652 | ) | (60,953 | ) | (70,662 | ) | - | ||||||||||
Numerator
for diluted earnings per share-
|
||||||||||||||||
income
available for common stockholders
|
||||||||||||||||
after
assumed conversions of debentures and
|
||||||||||||||||
exercise
of warrants
|
$ | (2,150 | ) | $ | 16,743 | $ | (6,328 | ) | $ | (29,278 | ) | |||||
Denominator:
|
||||||||||||||||
Weighted
average shares used to compute basic EPS
|
22,675,678 | 15,882,816 | 22,675,678 | 14,785,746 | ||||||||||||
Effect
of dilutive securities:
|
||||||||||||||||
Employee
stock options
|
76,319 | 370,410 | 118,522 | - | ||||||||||||
Derivative
warrants
|
- | 7,025,750 | - | - | ||||||||||||
Convertible
debentures
|
202,777,415 | 24,829,170 | 200,102,566 | - | ||||||||||||
Convertible
preferred stock
|
76,575,018 | 19,820,590 | 76,195,302 | - | ||||||||||||
Dilutive
potential common shares
|
279,428,752 | 52,045,920 | 276,416,390 | - | ||||||||||||
Denominator
for diluted earnings per share-
|
||||||||||||||||
adjusted
weighted average shares and assumed
|
||||||||||||||||
conversions
|
302,104,430 | 67,928,736 | 299,092,068 | 14,785,746 | ||||||||||||
Basic
earning per share
|
$ | 0.42 | $ | 4.89 | $ | 2.84 | $ | (1.98 | ) | |||||||
Diluted
earnings per share
|
$ | (0.01 | ) | $ | 0.25 | $ | (0.02 | ) | $ | (1.98 | ) |
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Stock
options
|
839,830 | 737,071 | 872,662 | 904,554 | ||||||||||||
Warrants
|
13,465,035 | 67,583 | 12,459,085 | 10,063,708 | ||||||||||||
Convertible
debt
|
- | - | - | 24,829,170 | ||||||||||||
Convertible
preferred stock
|
- | - | - | 19,820,590 | ||||||||||||
14,304,865 | 804,654 | 13,331,747 | 55,618,022 |
Pronouncement
|
Issued
|
Title
|
||
ASU
No. 2010-12
|
April
2010
|
Income
Taxes (Topic 740): Accounting for Certain Tax Effects of the 2010 Health
Care Reform Acts
|
||
ASU
No. 2010-13
|
April
2010
|
Compensation—Stock
Compensation (Topic 718): Effect of Denominating the Exercise Price of a
Share-Based Payment Award in the Currency of the Market in Which the
Underlying Equity Security Trades (A consensus of the FASB Emerging Issues
Task Force)
|
||
ASU
No. 2010-14
|
April
2010
|
Accounting
for Extractive Activities—Oil & Gas—Amendments to Paragraph
932-10-S99-1 (SEC Update)
|
||
ASU
No. 2010-15
|
April
2010
|
Financial
Services—Insurance (Topic 944): How Investments Held through Separate
Accounts Affect an Insurer’s Consolidation Analysis of Those Investments—a
consensus of the FASB Emerging Issues Task Force
|
||
ASU
No. 2010-16
|
April
2010
|
Entertainment—Casinos
(Topic 924): Accruals for Casino Jackpot Liabilities—a consensus of the
FASB Emerging Issues Task Force
|
||
ASU
No. 2010-17
|
April
2010
|
Revenue
Recognition—Milestone Method (Topic 605): Milestone Method of Revenue
Recognition—a consensus of the FASB Emerging Issues Task
Force
|
||
ASU
No. 2010-18
|
April
2010
|
Receivables
(Topic 310): Effect of a Loan Modification When the Loan is Part of a Pool
That is Accounted for as a Single Asset—a consensus of the FASB Emerging
Issues Task Force
|
||
ASU
No. 2010-19
|
May
2010
|
Foreign
Currency (Topic 830): Foreign Currency Issues: Multiple Foreign Currency
Exchange Rates
|
||
ASU
No. 2010-20
|
July
2010
|
Receivables
(Topic 310): Disclosures about the Credit Quality of Financing Receivables
and the Allowance for Credit Losses
|
||
ASU
No. 2010-21
|
|
August
2010
|
|
Accounting
for Technical Amendments to Various SEC Rules and Schedules Amendments to
SEC Paragraphs Pursuant to Release No. 33-9026: Technical Amendments to
Rules, Forms, Schedules and Codification of Financial Reporting Policies
(SEC
Update)
|
Proceeds
|
Deemed
|
Total
|
||||||||||
Allocation
|
Dividend
|
Allocation
|
||||||||||
(in thousands)
|
||||||||||||
Gross
proceeds
|
$ | 2,500 | $ | 2,500 | ||||||||
Financing
costs paid to investor
|
(100 | ) | (100 | ) | ||||||||
$ | 2,400 | $ | 2,400 | |||||||||
Derivative
liabilities:
|
||||||||||||
Investor
warrants
|
$ | (2,431 | ) | $ | (2,431 | ) | ||||||
Compound
derivative
|
(4,551 | ) | (4,551 | ) | ||||||||
Total
derivative liabilities
|
(6,982 | ) | (6,982 | ) | ||||||||
Redeemable
preferred stock:
|
||||||||||||
Series
D Preferred Stock
|
- | - | - | |||||||||
Deemed
dividend
|
- | $ | (2,500 | ) | (2,500 | ) | ||||||
Total
redeemable preferred stock
|
- | (2,500 | ) | (2,500 | ) | |||||||
Accumulated
deficit (deemed dividend)
|
- | 2,500 | 2,500 | |||||||||
Day-one
derivative loss
|
4,582 | 4,582 | ||||||||||
$ | (2,400 | ) | $ | - | $ | (2,400 | ) |
Proceeds
|
Settlement of
|
|||||||||||
Received
|
April 2010 Note
|
Total
|
||||||||||
(in
thousands)
|
||||||||||||
Gross
proceeds
|
$ | (1,500 | ) | $ | (506 | ) | $ | (2,006 | ) | |||
Structuring
and due diligence fee
|
90 | - | 90 | |||||||||
$ | (1,410 | ) | $ | (506 | ) | $ | (1,916 | ) | ||||
Derivative
liabilities:
|
||||||||||||
Investor
warrants
|
$ | (684 | ) | $ | (228 | ) | $ | (912 | ) | |||
Compound
derivative
|
(1,473 | ) | (491 | ) | (1,964 | ) | ||||||
Total
derivative liabilities
|
(2,157 | ) | (719 | ) | (2,876 | ) | ||||||
Day
one derivative loss
|
747 | - | 747 | |||||||||
Convertible
debenture-initial carrying value
|
- | (150 | ) | (150 | ) | |||||||
Loss
on extinguishment
|
- | 363 | 363 | |||||||||
$ | (1,410 | ) | $ | (506 | ) | $ | (1,916 | ) |
Default
|
Conversion Price – Lower of Fixed Price or Percentage of
VWAP for Preceding Period
|
||||||||||||||||||
Face
|
Interest
|
Interest
|
Fixed
|
Default
|
Preceding
|
||||||||||||||
Debenture Issue Date
|
Amount
|
Maturity
|
Rate
|
Rate
|
Price
|
%
|
%
|
Period
|
|||||||||||
August
24, 2006
|
$ | 5,000,000 |
7/29/2012
|
10%
|
n/a
|
$ | 2.00 |
90%
|
n/a
|
125
Days
|
|||||||||
December
29, 2006
|
$ | 2,500,000 |
7/29/2012
|
10%
|
n/a
|
$ | 2.00 |
90%
|
n/a
|
125
Days
|
|||||||||
March
27, 2007
|
$ | 7,458,651 |
7/29/2012
|
13%
|
n/a
|
$ | 2.00 |
90%
|
n/a
|
125
Days
|
|||||||||
August
24, 2007
|
$ | 1,775,000 |
7/29/2012
|
14%
|
|
n/a
|
$ | 2.00 |
80%
|
n/a
|
125
Days
|
||||||||
April
11, 2008
|
$ | 390,000 |
7/29/2012
|
15%
|
24%
|
$ | 1.50 |
80%
|
75%
|
125
Days
|
|||||||||
May
16, 2008
|
$ | 500,000 |
7/29/2012
|
15%
|
24%
|
$ | 1.50 |
80%
|
50%
|
125
Days
|
|||||||||
May
29, 2008
|
$ | 790,000 |
7/29/2012
|
15%
|
|
24%
|
$ | 1.00 |
80%
|
50%
|
125
Days
|
||||||||
July
10, 2008
|
$ | 137,750 |
7/29/2012
|
15%
|
24%
|
$ | 1.00 |
80%
|
50%
|
125
Days
|
|||||||||
July
29, 2008
|
$ | 2,325,000 |
7/29/2012
|
14%
|
|
24%
|
$ | 2.00 |
95%
|
50%
|
125
Days
|
||||||||
October
28, 2008
|
$ | 2,325,000 |
7/29/2012
|
14%
|
20%
|
$ | 2.00 |
95%
|
50%
|
125
Days
|
|||||||||
May
1, 2009
|
$ | 294,000 |
7/29/2012
|
14%
|
20%
|
$ | 2.00 |
95%
|
50%
|
125
Days
|
|||||||||
June
5, 2009
|
$ | 715,000 |
7/29/2012
|
14%
|
20%
|
$ | 2.00 |
95%
|
50%
|
125
Days
|
|||||||||
July
15, 2009
|
$ | 535,000 |
7/29/2012
|
14%
|
20%
|
$ | 2.00 |
95%
|
50%
|
125
Days
|
|||||||||
August
14, 2009
|
$ | 475,000 |
7/29/2012
|
14%
|
20%
|
$ | 2.00 |
95%
|
50%
|
125
Days
|
|||||||||
May
27, 2010
|
$ | 2,006,137 |
7/29/2012
|
14%
|
20%
|
$ | 0.30 |
95%
|
50%
|
60
Days
|
Remaining
|
Equivalent
|
Equivalent
|
||||||||||
Conversion
|
Term
|
Equivalent
|
Interest-Risk
|
Credit-Risk
|
||||||||
Prices
|
(years)
|
Volatility
|
Adjusted Rate
|
Adjusted Rate
|
||||||||
Series
C Convertible Preferred Stock
|
$ | 0.15 | 2.08 | 187% | 7.51% | 8.59% | ||||||
Series
D Convertible Preferred Stock
|
$
|
0.15
|
2.08 | 187% | 7.51% | 8.59% | ||||||
|
||||||||||||
August
24, 2006
|
$
|
0.14
|